Healthcare providers can now integrate EHR and other industry data with ChatGPT
healthcare
| Source: OpenAI | Original article
ChatGPT now integrates with electronic health records and other trusted healthcare data, enabling clinicians to securely access patient context and medical research.
OpenAI has expanded its ChatGPT Health platform, allowing healthcare providers to link their electronic health‑record (EHR) systems and other industry data sources directly to the chatbot. The move builds on the company’s earlier announcement that it would integrate ChatGPT with Epic’s EHR, which stores information for more than 325 million patients. By connecting to trusted clinical data, clinicians can now pose natural‑language questions and receive answers that draw on appointment notes, lab results, medication histories, specialist reports and broader medical research—all without manually sifting through disparate records.
The integration matters because it promises to cut the time clinicians spend hunting for information, a bottleneck that can delay diagnosis and treatment. Secure, AI‑driven access to a patient’s full context also opens the door to more personalized care recommendations and faster identification of relevant studies or guidelines. For health systems, the capability could improve workflow efficiency and reduce administrative overhead, while patients may benefit from more informed clinical decisions.
OpenAI says the connections are built to meet healthcare‑industry security standards, but the rollout will be closely watched for compliance with privacy regulations such as HIPAA and for how well the system safeguards sensitive data. As we reported on 1 September 2026, the initial Epic integration marked the first step; the current expansion signals a broader strategy to embed generative AI across the health data stack.
What to monitor next are the timelines for wider deployment, adoption rates among hospitals and clinics, and whether additional EHR vendors or specialty data providers join the ecosystem. Regulators, clinicians and patient‑advocacy groups are likely to scrutinise the balance between AI convenience and data protection as the technology moves from pilot to routine use.
Sources
Back to AIPULSEN